

Fundamental dimension Equity attribute | BTAIPeer $0.0739▲+64.22% Cap $2.28MP/E -0.0x QuantScore34/100 | ANVSPeer $0.9993▲+0.77% Cap $42.65MP/E -0.6x QuantScore35/100 | BCABLeader $1.74▲+31.44% Cap $2.88MP/E -0.1x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
43/100 |
16/100 |
49/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 45/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 23/100 | 40/100 | 33/100 |
Growth Revenue / earnings growth & margins | 36/100 | 0/100 | 60/100 |
Sentiment Analyst ratings, targets & revisions | 69/100 | 77/100 | 81/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.6x | -0.1x |
Forward P/E (next FY) | -0.0x | -0.7x | -0.0x |
EV / EBITDA (TTM) | -1.8x | -0.5x | -0.2x |
Price / Sales | 3.1x | — | 0.3x |
Price / Free Cash Flow | -0.0x | -1.0x | -0.1x |
PEG ratio | -0.00 | 0.49 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 1 / 9 | 4 / 9 |
Altman Z-Score | -46.97 (Distress) | -18.19 (Distress) | -93.50 (Distress) |
Total debt / equity | -0.90 | 0.00 | -0.16 |
Quick ratio | 0.2x | 2.9x | 0.2x |
Interest coverage | -2.6x | -31.2x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -71.7% | — | -81.8% |
Net income growth YoY | -17.3% | -17.3% | +14.6% |
Gross margin (TTM) | 45.3% | 0.0% | 100.0% |
Operating margin (FY) | -7829.8% | — | -2965.3% |
FCF margin (FY) | -8974.3% | — | -2410.2% |
5. Trailing price performancePrice change over period |
1M return | -0.1% | -24.9% | -44.7% |
3M return | -93.3% | -39.8% | -52.9% |
6M return | -93.5% | -42.6% | -77.3% |
Year to date | -95.4% | -71.1% | -93.9% |
1Y return | -97.1% | -51.3% | -95.0% |
3Y return | -99.8% | -87.4% | -98.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-7.81 -10667.5% premium | $0.8364 -16.3% premium | $-4.95 -385.3% premium |
Wall Street consensus target | $12.00 +16138.2% · range $1.00–$25.00 | $25.67 +2468.8% · range $21.00–$30.00 | $250.00 +14309.2% · range $250.00–$250.00 |
Consensus stance | 53% Buy40% Hold7% Sell | 78% Buy22% Hold-0% Sell | 67% Buy33% Hold0% Sell |